(Q67395144)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1232527%20AND%20SRC:MED&resulttype=core&format=json

12 September 2019

title

Adriamycin: a new effective agent in the therapy of disseminated sarcomas (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1232527%20AND%20SRC:MED&resulttype=core&format=json

12 September 2019

Adriamycin: A new effective agent in the therapy of disseminated sarcomas (English)

1 reference

https://api.crossref.org/works/10.1002/MPO.2950010109

3 November 2023

1 reference

1 reference

https://api.crossref.org/works/10.1002/MPO.2950010109

3 November 2023

2

P H Wiernik

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1232527%20AND%20SRC:MED&resulttype=core&format=json

12 September 2019

author name string

R. S. Benjamin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1232527

3 September 2022

N. R. Bachur

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1232527

3 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1232527

3 September 2022

publication date

1 January 1975

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1232527%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

12 September 2019

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmpo.2950010109

1 reference

https://api.crossref.org/works/10.1002/MPO.2950010109

https://onlinelibrary.wiley.com/doi/full/10.1002/mpo.2950010109

3 November 2023

1 reference

https://api.crossref.org/works/10.1002/MPO.2950010109

3 November 2023

published in

Pediatric Blood Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1232527%20AND%20SRC:MED&resulttype=core&format=json

Medical and Pediatric Oncology

12 September 2019

1

1

63–76

1975

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1232527

3 September 2022

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1232527%20AND%20SRC:MED&resulttype=core&format=json

12 September 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1232527%20AND%20SRC:MED&resulttype=core&format=json

12 September 2019

page(s)

63-76

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1232527%20AND%20SRC:MED&resulttype=core&format=json

12 September 2019

1

30

2572

Bonadonna

1970

1 reference

https://api.crossref.org/works/10.1002/MPO.2950010109

Clinical trials with adriamycin

3 November 2023

2

1 reference

https://api.crossref.org/works/10.1002/MPO.2950010109

Therapeutic effect and toxicity of adriamycin in patients with neoplastic disease

3 November 2023

3

1 reference

https://api.crossref.org/works/10.1002/MPO.2950010109

Pharmacokinetics and metabolism of adriamycin in man

3 November 2023

4

1 reference

https://api.crossref.org/works/10.1002/MPO.2950010109

The pharmacokinetics of daunomycin in man

3 November 2023

5

1 reference

https://api.crossref.org/works/10.1002/MPO.2950010109

Daunorubicin metabolism in acute nonlymphocytic leukemia

3 November 2023

6

1 reference

https://api.crossref.org/works/10.1002/MPO.2950010109

Adriamycin chemotherapy--efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule.

3 November 2023

7

1 reference

https://api.crossref.org/works/10.1002/MPO.2950010109

A generalized Wilcoxon test for comparing arbitrarily singly-censored samples

3 November 2023

11

1 reference

https://api.crossref.org/works/10.1002/MPO.2950010109

A clinicopathologic analysis of adriamycin cardiotoxicity

3 November 2023

12

1 reference

https://api.crossref.org/works/10.1002/MPO.2950010109

Doxorubicin in disseminated osteosarcoma

3 November 2023

13

1 reference

https://api.crossref.org/works/10.1002/MPO.2950010109

Adriamycin--an antitumor antibiotic in the treatment of neoplastic diseases

3 November 2023

15

1 reference

https://api.crossref.org/works/10.1002/MPO.2950010109

Adriamycin. A new anticancer drug with significant clinical activity

3 November 2023

17

1 reference

https://api.crossref.org/works/10.1002/MPO.2950010109

Chemotherapy of sarcomas with a combination of adriamycin and dimethyl triazeno imidazole carboxamide

3 November 2023

18

1 reference

https://api.crossref.org/works/10.1002/MPO.2950010109

Extended combination therapy of childhood rhabdomyosarcoma

3 November 2023

19

1 reference

https://api.crossref.org/works/10.1002/MPO.2950010109

Evaluation of a high dose cyclophosphamide regimen in childhood tumors.

3 November 2023

22

1 reference

https://api.crossref.org/works/10.1002/MPO.2950010109

3 November 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1232527%20AND%20SRC:MED&resulttype=core&format=json

12 September 2019

1 reference